Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis

Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have shown benefits in improving cardiovascular (CV) outcomes in patients with heart failure (HF) and may mitigate symptom progression in myocardial infarction (MI). However, their effectiveness in patients with type 2 diabetes and MI un...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huzaifa Ul Haq Ansari, Muhammad Ammar Samad, Eman Mahboob, Eeshal Zulfiqar, Shurjeel Uddin Qazi, Areeba Ahsan, Mushood Ahmed, Faizan Ahmed, Raheel Ahmed, Shafaqat Ali, Mahboob Alam, Jamal S. Rana, Gregg C. Fonarow
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	American Journal of Preventive Cardiology
Subjects:	Sodium-glucose co-transporter 2 inhibitors Type 2 diabetes Myocardial infarction Percutaneous coronary intervention
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667724002964
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation
by: Christodoulos Dolapsakis, et al.
Published: (2025-01-01)

Ectopic expression of the cation-chloride cotransporter KCC2 in blood exosomes as a biomarker for functional rehabilitation
by: L. Caccialupi Da Prato, et al.
Published: (2025-02-01)

The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors)
by: Denda Nikola I., et al.
Published: (2024-01-01)

Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema
by: Takuya Oyakawa, et al.
Published: (2025-01-01)

Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation
by: Selim Aydemir, et al.
Published: (2024-12-01)

Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01)

In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
by: Halim Sobia Ahsan, et al.
Published: (2021-03-01)

Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
by: Riber Fabián Donoso Noroña, et al.
Published: (2024-09-01)

Study of cardiovascular risk in type 2 diabetic patients in the acute phase of the coronavirus infection and post-COVID period on the background of therapy with sodium-glucose cotransporter-2 inhibitors
by: N.M. Kushnarоva, et al.
Published: (2024-12-01)

Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
by: Waseem Amjad, et al.
Published: (2022-01-01)

Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01)

Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD)
by: Min-Jia Cao, et al.
Published: (2025-01-01)

Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
by: Michele Maremmani, et al.
Published: (2025-01-01)

The impact of sodium-glucose cotransporter-2 inhibitors on the incidence, therapy, and outcomes of fournier gangrene: insights from a systematic review of case reports
by: Yufi Aulia Azmi, et al.
Published: (2025-01-01)

FORECASTING OF POTATO YIELD ESTIMATION BY SATELLITE BASED REMOTE SENSING TECHNIQUE
by: Mohammad Mukhlesur Rahman, et al.
Published: (2024-05-01)

Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging
by: Agena Suzuki, et al.
Published: (2024-08-01)

Design and synthesis of antiproliferative 2-oxoindolin-3-ylidenes incorporating urea function with potential VEGFR-2 inhibitory properties
by: Dalia R. Aboshouk, et al.
Published: (2025-01-01)

Risk of diabetic ketoacidosis caused by sodium glucose cotransporter-2 inhibitors in patients with type 1 diabetes: a systematic review and network meta-analysis of randomized controlled trials
by: Ying Liu, et al.
Published: (2025-01-01)

Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database
by: Go Anan, et al.
Published: (2023-11-01)

Synthesis of 2H-azirine-2,2-dicarboxylic acids and their derivatives
by: Anastasiya V. Agafonova, et al.
Published: (2024-12-01)

Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence
by: Jian‐Yu Jhu, et al.
Published: (2025-02-01)

FRICTION PRESSURE PREDICTION OF SUPERCRITICAL CO2 TURBULENT FLOW IN A CONCENTRIC ANNULUS
by: Md. Uddin, et al.
Published: (2025-01-01)

The Comparison and Correlation of Serum Levels of Insulin and Na+/ K+ Atpase In Type 2 Diabetes Mellitus (T2DM) And Non-Diabetes Mellitus Individuals
by: Karar Kazem Mohammed, et al.
Published: (2022-09-01)

O2·- 和H2O2表达上调对2 型糖尿病患者血小板异常活化的影响
by: 陈菲, et al.
Published: (2017-01-01)

The role of cyclooxygenase-2 (COX-2) and inflammatory markers in the progress of Alport syndrome in Egyptian children
by: Moushira Zaki, et al.
Published: (2025-01-01)

Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
by: Alaa Abed Mahmoud, et al.
Published: (2023-06-01)

The L2 motivational self system, L2 interest, and L2 anxiety: A study of motivation and gender differences in the Croatian context
by: Martinović Anna, et al.
Published: (2018-10-01)

COX-2与BCL-2的表达与皮肤肿瘤的关系
by: 毛越苹, et al.
Published: (2006-01-01)

Hyperoxia-activated Nrf2 regulates ferroptosis in intestinal epithelial cells and intervenes in inflammatory reaction through COX-2/PGE2/EP2 pathway
by: Yanping Liu, et al.
Published: (2025-01-01)

Coverage Probability and Area Spectral Efficiency of Full Duplex Communication in C-V2X Network With Dual Connectivity
by: Adeel Ahmad, et al.
Published: (2024-01-01)

Complexes of vertebrate TMC1/2 and CIB2/3 proteins form hair-cell mechanotransduction cation channels
by: Arnaud PJ Giese, et al.
Published: (2025-01-01)

Survey of software defined D2D and V2X communication
by: Wenjuan SHAO, et al.
Published: (2019-04-01)

Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy
by: Kengo Tanigawa, et al.
Published: (2025-12-01)

NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2
by: Mohsen Nakhaei, et al.
Published: (2023-10-01)

Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer
by: Yisun Jeong, et al.
Published: (2024-12-01)

GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care
by: Agnieszka Parfianowicz, et al.
Published: (2025-02-01)

Advancing forensic investigations based on TiO2/Bi2O3 electrochemical sensor for precise potassium estimation in vitreous humor
by: Zulfiqar Ali Buzdar, et al.
Published: (2025-01-01)

Carbonitriding reduction of TiO2 in the CH4-H2-N2 system: Reduction temperature effect and kinetics
by: Zhang R., et al.
Published: (2024-01-01)

Microwave-induced degradation of Congo red dye in the presence of 2D Ti3C2Tx MXene as a catalyst
by: Salma M. El-Mas, et al.
Published: (2025-01-01)

Ultrasonic treatment-assisted reductive deposition of Cu and Pd nanoparticles on ultrathin 2D Bi2S3 nanosheets for selective electrochemical reduction of CO2 into C2 compounds
by: Bilal Masood Pirzada, et al.
Published: (2025-01-01)